Skip to main content
. Author manuscript; available in PMC: 2013 Jan 23.
Published in final edited form as: N Engl J Med. 2011 Sep 7;365(11):993–1003. doi: 10.1056/NEJMoa1105335

Table 1.

Baseline Characteristics of the Patients.*

Characteristic Medical-Management
Group
(N = 227)
PTAS Group
(N = 224)
Age — yr 59.5±11.8 61.0±10.7
Male sex — no. (%) 145 (63.9) 127 (56.7)
Race — no. (%)
 Black 50 (22.0) 55 (24.6)
 White 161 (70.9) 160 (71.4)
 Other 16 (7.0) 9 (4.0)
Hypertension — no. (%) 203 (89.4) 201 (89.7)
Diabetes — no. (%) 103 (45.4) 106 (47.3)
Lipid disorder — no. (%) 203 (89.4) 194 (86.6)
Smoking history — no./total no. (%)
 Never 78/227 (34.4) 90/223 (40.4)
 Former 80/227 (35.2) 79/223 (35.4)
 Current 69/227 (30.4) 54/223 (24.2)
History of coronary artery disease — no. (%) 59 (26.0) 47 (21.0)
History of stroke other than qualifying event — no. (%) 58 (25.6) 60 (26.8)
Qualifying event — no. (%)
 Stroke 152 (67.0) 142 (63.4)
 TIA 75 (33.0) 82 (36.6)
Already receiving antithrombotic therapy at time of qualifying event —
  no. (%)
141 (62.1) 145 (64.7)
Time from qualifying event to randomization — days
 Median 7 7
 Interquartile range 4–19 4–16
Symptomatic qualifying artery — no. (%)
 Internal carotid 49 (21.6) 45 (20.1)
 Middle cerebral 105 (46.3) 92 (41.1)
 Vertebral 22 (9.7) 38 (17.0)
 Basilar 51 (22.5) 49 (21.9)
Stenosis of symptomatic qualifying artery
Mean percentage stenosis 81±7 80±7
Distribution — no./total no. (%)
  70–79% stenosis 102/227 (44.9) 107/223 (48.0)
  80–89% stenosis 97/227 (42.7) 92/223 (41.3)
  90–99% stenosis 28/227 (12.3) 24/223 (10.8)
*

Plus–minus values are means ±SD. Baseline characteristics of the two groups were compared with the use of either an independent groups t-test (for means) or a chi-square test (for percentages). None of the characteristics differed significantly between the groups (P<0.05 for all comparisons). PTAS denotes percutaneous transluminal angioplasty and stenting.

Race was self-reported.

Stenosis was quantified on the basis of a reading of the angiogram by the site interventionist.